Search
Search Results
##search.searchResults.foundPlural##
-
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1289PDF: 673HTML: 7753 -
-
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4260PDF: 1998HTML: 1946 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1079PDF: 572HTML: 7880 -
IMPLEMENTATION OF MICROELIMINATION STRATEGY IN ERADICATION OF CHRONIC HEPATITIS C INFECTION IN PATIENTS WITH HEMOPHILIA IN THE NORTHERN REGION OF SERBIA Microelimination Strategy of Chronic Hepatitis C Infection in patients with Hemophilia
925PDF: 396HTML: 154 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1022PDF: 546HTML: 737 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2291PDF: 1191HTML: 2602Study of serum haptoglobin level in thalassemia: 375Figures: 200 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1701PDF: 1033HTML: 546 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4354PDF: 1550HTML: 463 -
PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?
2990PDF: 1005HTML: 2110Cover letter: 189 -
-
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4538PDF: 1513HTML: 8530 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
4027PDF: 1343HTML: 2493 -
OCCULT HEPATITIS B VIRUS INFECTION AND ASSOCIATED GENOTYPES AMONG HBSAG-NEGATIVE SUBJECTS IN BURKINA FASO
4671PDF: 1225HTML: 496Figure: 251 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1651PDF: 834HTML: 1275Figure 1: 187Figure 2: 201Figure 3: 198 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1418PDF: 780HTML: 536 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1485PDF: 1359HTML: 111 -
-
SEROPOSITIVITY OF HEPATITIS B AND C AMONG SYRIAN MULTITRANSFUSED PATIENTS WITH HEMOGLOBINOPATHY
3414PDF: 772HTML: 1124Cover Letter: 214 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1351PDF: 481HTML: 18620Figure 1: 179Figure 2: 160Figure 3: 177Figure 4: 215Figure 5: 188 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1764PDF: 754HTML: 238 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1625PDF: 869HTML: 1078Picture 1: 187 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3304PDF: 1048HTML: 2280 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
1106PDF: 1011Suppl. Files: 474HTML: 352 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
878PDF: 493HTML: 1310 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2937PDF: 1130HTML: 126 -
PREVENTION OF POST-TRANSFUSION HEPATITIS BY SCREENING OF ANTIBODY TO HEPATITIS B CORE ANTIGEN IN HEALTHY BLOOD DONORS
1202PDF: 709HTML: 1270Title page: 220 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1645PDF: 1007HTML: 223 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3346PDF: 1608HTML: 284







